GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) announced the resignation of Sunder Ramachandran as Head of Commercial Excellence, with effect from January 12, 2024.
According to the company’s exchange filing, “we hereby inform you that Mr. Sunder Ramachandran – Head of Commercial Excellence, has tendered his resignation effective from the close of business hours on 12th January 2024 to pursue other opportunities outside of the Company. As a result, he will also cease to be a Senior Management Personnel of the Company.”
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GSK plc, a global biopharma company.
